Irbesartan Comp. Abz

Irbesartan, the active ingredient in Irbesartan Comp. Abz, is an Angiotensin II receptor blocker presented as an oral tablet formulation for oral use. It is combined with hydrochlorothiazide to treat hypertension in adult patients, helping to lower elevated blood pressure. It is indicated for patients who require combined antihypertensive therapy to achieve target blood pressure levels.

GNH USA supplies Irbesartan Comp. Abz as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and providing the product to hospitals, pharmacies and clinics worldwide through regulated distribution channels.

Irbesartan/Hydrochlorothiazide is used in the management of hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension in type 2 diabetes: assists in blood pressure control while offering renal protective effects. - Hypertension with fluid retention: combines vasodilation and diuresis to reduce excess fluid and improve blood pressure control.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Increased urination. - Electrolyte disturbances, such as low potassium. - Mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe allergic reactions (rash, swelling, difficulty breathing). - Acute kidney injury or worsening renal function. - Significant hypotension (dangerously low blood pressure). - Hyperkalemia (high potassium levels). - Pancreatitis. - Blood dyscrasias (e.g., agranulocytosis).

Patients should be monitored regularly while taking this medication.

- Monitor blood pressure: ensure therapeutic targets are reached without excessive lowering. - Assess renal function: check serum creatinine and eGFR before initiation and periodically thereafter. - Check electrolytes: especially potassium and sodium levels during therapy. - Avoid use in pregnancy: the drug is contraindicated due to fetal risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Irbesartan/Hydrochlorothiazide may interact with several medicines.

Major Interactions (Avoid): - Aliskiren in patients with diabetes: increased risk of renal impairment. - Potassium‑sparing diuretics or potassium supplements: may cause hyperkalemia. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can diminish antihypertensive effect and affect kidney function.

Moderate Interactions (Monitor Closely): - Other antihypertensive agents: additive blood pressure‑lowering effect. - Lithium: may increase lithium concentrations. - Cyclosporine: can raise serum creatinine levels.